BioSpace News Archive

Business

Novartis Harnesses Molecular Partners’ DARPin Technology Against COVID-19

Novartis is harnessing the power of Molecular Partners AG’s DARPin platform to develop two therapeutic candidates that could both be used to prevent and treat COVID-19 infection.

October 28, 2020
·
3 min read
·
Alex Keown
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq

Two years ago, Cerevel Therapeutics spun out of Pfizer. It then took an unusual approach, merging with a special purpose acquisition company, Arya Sciences Acquisition Corp II. Arya was designed specifically to acquire or merge with another company.

October 28, 2020
·
3 min read
·
Mark Terry
BioSpace Global Roundup, Oct. 29

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

October 28, 2020
·
5 min read
·
Alex Keown
Business

BIO-Europe® Digital: Kidney Disease Therapeutics on Cusp of Transformative Innovation

Kidney disease hasn’t been an area of vibrant transformation, but it is emerging as a promising and area for diagnostic and therapeutic investigation following an explosion of foundational technologies in recent years, according to speakers at BIO-Europe® Digital, held virtually October 26-29.

October 28, 2020
·
4 min read
·
Gail Dutton
Business

Insitro and BMS Team Up to Pave the Way for New ALS and FTD Treatments

Through this collaboration, Insitro will utilize its proprietary platform, Insitro Human (ISH), to create induced pluripotent stem cell (iPSC) derived disease models for both diseases.

October 28, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Enrollment Grows as Clinical Trials Become More Innovative During Pandemic

Recent Greenphire data shows new participant enrollment up 85% since slump in April.

October 28, 2020
·
3 min read
·
Kate Goodwin
Business

Texas is “Going Big” in Biopharma

Texas wants to get the word out: It’s not just for oil and pipelines anymore. The Lone Star State is a rapidly emerging biopharma hub, with more than just a lone focus on oncology.

October 28, 2020
·
6 min read
·
Heather McKenzie
BioMidwest

Newly Discovered Immune Cell May Rescue and Reverse Nerve Damage

A pro-regenerative cell discovered by researchers at Ohio State and the University of Michigan could open the door to potentially groundbreaking immunotherapeutic treatments for diseases such as ALS and multiple sclerosis.

October 28, 2020
·
2 min read
·
Heather McKenzie
Career Advice

Scientist I, Scientist II and Senior Scientist Roles, Explained

Being able to tell the difference between various life science roles can be difficult. To help, here is a guide to three commonly confused roles: Scientist I, Scientist II and Senior Scientist.

October 28, 2020
·
2 min read
·
Porschia Parker-Griffin
Athersys Preps MultiStem® Stroke Therapy for Approval Under Japan’s RegenMed Law

When Japan’s landmark regenerative medicine legislation took effect in 2014, it opened an entirely new market for biotech innovators. Athersys, a leader in regenerative medicine, seized the opportunity.

October 28, 2020
·
4 min read
·
Gail Dutton